Main analysis papers from NEJM in 2023

Here’s a nice shock, a collectors problem of NEJM yr e book 2023, is made accessible free (even for non subscribers, in its web site) .It’s fascinating to understand how quick the Inner drugs has grown. For the busy cardiologists, this may a be refreshing reminder, that there are different necessary organs and specialties do exist in drugs , with equal breakthroughs and Improvements.

It’s certainly a tremendous , whirlwind tour of drugs for all those that see medical science as single holistic specialty. It has articles, starting from from easy medical research on postpartum hemorrhage (E-MOTIVE research) from deep inside Africa by Melinda Gate basis, to Dupilumab for COPD, a beautiful monoclonal antibody inhibitor of IL-4 for COPD exacerbations. Shortening tuberculosis remedy with a technique involving preliminary remedy with an 8-week Bedaquiline-linezolid routine (TRUNCATE-TB research) can also be a revelation.

Of-course, the necessary cardiac subjects do discover a outstanding place together with the at present omnipresent drug GLP agonist Semaglutide for HFpEF (STEP-HFpEF research). Baxdrostat, an Aldosterone synthase antagonist for treatment-resistant Hypertension, seems promising (BrigHTN).

Last message

Nevertheless, the crowning glory amongst all articles seem in the direction of the top of the doc, titled Combating misinformation as a core Operate of Public Well being.

Let me share the hyperlink to this PDF doc right here. Hope it permits open entry and there aren’t any copyright points. Notable articles of 2023 from NEJM .